SecBot SecBot
PRESS-RELEASE ·Filed Nov 17, 2026

MDLN

Medline Inc.
BEARISH
Impact 5/10
Horizondays Processed4d 10h ago WireGlobeNewswire
Press release · Offering
Actionable Insight ▼ Bearish

The secondary offering by major private equity holders signals a potential exit or partial monetization, which could weigh on the stock in the near term. The $200 million repurchase partially offsets selling pressure but is small relative to the $2.13 billion offering. Monitor the closing and any subsequent insider selling patterns.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1
Entry
$39.16
T+0 close · Nov 17, 2026 · via day close
Latest settled
−3.37%
T+1 · $37.84 · next T+5 in 3d
Vs SPY
−1.41%
α at T+1
Latest observation
−0.48%
T+2 · FF3 residual α
  1. T+0 · Nov 18 $39.16entry
  2. T+1 · 3d ago −3.37%α −1.41% · $37.84
  3. T+2 · todayOpen
  4. T+5 · in 3d Pending
  5. T+20 · in 25d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Medline Inc. announced a secondary offering of 60 million shares at $35.50 per share by selling stockholders (Blackstone, Carlyle, Hellman & Friedman, GIC, ADIA), with an additional 9 million share over-allotment option. Medline will not receive any proceeds, but will repurchase $200 million of its own stock from the selling stockholders concurrently. The offering represents approximately 6.5% dilution based on the company's market cap, but the selling pressure is from existing holders, not new share issuance by the company.

Key Financial Metrics

Deal Value
$2.1B

Key Facts

  • Secondary offering of 60,000,000 shares of Class A common stock at $35.50 per share by selling stockholders
  • Underwriters have a 30-day option to purchase up to an additional 9,000,000 shares
  • Medline will not receive any proceeds from the offering
  • Medline will repurchase $200 million of its Class A common stock and Common Units from selling stockholders at the offering price
  • Offering expected to close on November 23, 2026
  • Selling stockholders include Blackstone, Carlyle, Hellman & Friedman, GIC, and ADIA

Financial Impact

60 million shares at $35.50 per share = $2.13 billion total offering size; $200 million concurrent stock repurchase by Medline

dilutionshare count

Risk Factors

  • Large secondary offering by major shareholders could create downward price pressure
  • Over-allotment option adds potential for additional 9 million shares (another $319.5 million) if exercised
  • Selling stockholders are major institutional holders, suggesting reduced long-term commitment

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
79% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3405359

Track record

34 reports on MDLN

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 6 of 9 went positive at some point.

Filters
  1. Nov 19, 20262d ago 424B4 Bearish 5/10 Entry $39.04 Now $37.04 +5.12% settles Nov 30
  2. Nov 18, 20263d ago 8-K Neutral 4/10 Entry $37.84 Now $37.04 −2.11% settles Nov 27
  3. Nov 18, 20264d ago EFFECT Neutral 5/10 Entry $39.16 Now $37.04 −5.41% settles Nov 25
  4. Nov 17, 20264d ago Press Release Bearish 5/10 Viewing Entry $39.16 Now $37.04 +5.41% settles Nov 25
  5. Nov 16, 20266d ago Press Release Bearish 5/10 Entry $39.17 Now $37.04 +5.44% settles Nov 23
  6. Nov 16, 20266d ago S-1 Neutral 4/10 Entry $39.17 Now $37.04 −5.44% settles Nov 23
  7. Nov 13, 20268d ago SC 13G Neutral 3/10 Entry $39.17 Now $37.04 −5.44% settles Nov 23
  8. Nov 13, 20268d ago 144 Neutral 2/10 Entry $39.17 Now $37.04 −5.44% settles Nov 23
  9. Nov 6, 202615d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $37.04 −9.01% ▼ −3.78% −2.09% vs SPY
  10. Nov 4, 202618d ago 8-K Neutral 5/10 No price data
Showing 10 of 34

US Market Status

Market Closed · Opens Mon (25h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 17, 2026